The North America Drug Eluting Stent Market would witness market growth of 7.2% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 3,399.3 thousand units, showcasing a growth of 6.9% (2019-2022).
Stents are employed in operations like coronary angioplasty. Percutaneous coronary interventions (PCI), other coronary angioplasty procedures, and the therapy of coronary artery disease involve drug-eluting stents (DES). Three components comprise a drug eluting stent: the stent platform, the polymer coating (which keeps the medication inside the stent), and the drug itself. The danger of acquiring artery diseases rises with the aging population, increasing the need for efficient treatment alternatives like drug eluting stents.
The prevalence of atherosclerosis, defined by plaque development in the arteries, has increased due to sedentary lifestyles and poor dietary practices. Heart attacks and strokes, among other cardiovascular disorders, are considerably exacerbated by this disease. Due to this growing public health hazard, drug eluting stents are becoming more popular among medical professionals as a preferred method of treating atherosclerosis.
Additionally, reducing patient problems and the number and length of hospital stays have received significant attention as the healthcare industry reforms to switch from the present fee-for-service model to a fee-for-value model. Particularly in interventional cardiology, there has been a considerable evolution in device technology, operator techniques, clinical safety, and efficacy. Huge strides have been made in treating coronary artery disease, and patients today live in the era of "stent implantation."
Canada has also seen many cases of heart disease in recent years. Approximately 1 in 12 (or 2.6 million) Canadian adults age 20 and over have been diagnosed with heart disease, and every hour, roughly 14 Canadian adults age 20 and over with this diagnosis pass away, according to 2017–2018 statistics from the Canadian Chronic Disease Surveillance System (CCDSS). Likewise, the aging population is also a concern. According to the Government of Canada, over 861,000 older adults, or more than twice as many as were found in the 2001 Census, were counted in the 2021 Census. With a 12% increase over 2016, the population of people aged 85 and beyond is one of the age groups with the most significant growth. At the moment, 2.3% of people are 85 years of age or older. The abovementioned factors will present lucrative prospects for drug eluting stents in North America.
The US market dominated the North America Drug Eluting Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,570.1 million by 2030. The Canada market is experiencing a CAGR of 9.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.7% during (2023 - 2030).
Based on Application, the market is segmented into Coronary Artery Disease, and Peripheral Artery Disease. Based on Coating Type, the market is segmented into Polymer-based Coating (Non-biodegradable Polymers, and Biodegradable Polymers), and Polymer-free Coating (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, and Nanoporous Surface). Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Drug Eluting Stent Market is Predict to reach $13.2 Billion by 2030, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.), Cook Medical, Inc. (Cook Group), B. Braun Melsungen AG, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd and Alvimedica.
Scope of the Study
Market Segments Covered in the Report:
By Application (Volume, Thousand Units, USD Million, 2019-2030)
- Coronary Artery Disease
- Peripheral Artery Disease
By Coating Type (Volume, Thousand Units, USD Million, 2019-2030)
- Polymer-based Coating
- Non-biodegradable Polymers
- Biodegradable Polymers
- Polymer-free Coating
- Micro Porous Surface
- Micro Structured Surface
- Slotted Tubular Surface
- Nanoporous Surface
By Country (Volume, Thousand Units, USD Million, 2019-2030)
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic PLC
- Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
- Cook Medical, Inc. (Cook Group)
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Alvimedica
TABLE 1 North America Drug Eluting Stent Market, 2019 - 2022, USD Million
TABLE 2 North America Drug Eluting Stent Market, 2023 - 2030, USD Million
TABLE 3 North America Drug Eluting Stent Market, 2019 - 2022, Thousand Units
TABLE 4 North America Drug Eluting Stent Market, 2023 - 2030, Thousand Units
TABLE 5 North America Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
TABLE 6 North America Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
TABLE 7 North America Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
TABLE 8 North America Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
TABLE 9 North America Coronary Artery Disease Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Coronary Artery Disease Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Coronary Artery Disease Market by Country, 2019 - 2022, Thousand Units
TABLE 12 North America Coronary Artery Disease Market by Country, 2023 - 2030, Thousand Units
TABLE 13 North America Peripheral Artery Disease Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Peripheral Artery Disease Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Peripheral Artery Disease Market by Country, 2019 - 2022, Thousand Units
TABLE 16 North America Peripheral Artery Disease Market by Country, 2023 - 2030, Thousand Units
TABLE 17 North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
TABLE 18 North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
TABLE 19 North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
TABLE 20 North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
TABLE 21 North America Polymer-based Coating Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Polymer-based Coating Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Polymer-based Coating Market by Country, 2019 - 2022, Thousand Units
TABLE 24 North America Polymer-based Coating Market by Country, 2023 - 2030, Thousand Units
TABLE 25 North America Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
TABLE 26 North America Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
TABLE 27 North America Non-biodegradable Polymers Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Non-biodegradable Polymers Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Biodegradable Polymers Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Biodegradable Polymers Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Polymer-free Coating Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Polymer-free Coating Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Polymer-free Coating Market by Country, 2019 - 2022, Thousand Units
TABLE 34 North America Polymer-free Coating Market by Country, 2023 - 2030, Thousand Units
TABLE 35 North America Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
TABLE 36 North America Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
TABLE 37 North America Micro Porous Surface Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Micro Porous Surface Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Micro Structured Surface Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Micro Structured Surface Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Slotted Tubular Surface Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Slotted Tubular Surface Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Nanoporous Surface Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Nanoporous Surface Market by Country, 2023 - 2030, USD Million
TABLE 45 North America Drug Eluting Stent Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Drug Eluting Stent Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Drug Eluting Stent Market by Country, 2019 - 2022, Thousand Units
TABLE 48 North America Drug Eluting Stent Market by Country, 2023 - 2030, Thousand Units
TABLE 49 US Drug Eluting Stent Market, 2019 - 2022, USD Million
TABLE 50 US Drug Eluting Stent Market, 2023 - 2030, USD Million
TABLE 51 US Drug Eluting Stent Market, 2019 - 2022, Thousand Units
TABLE 52 US Drug Eluting Stent Market, 2023 - 2030, Thousand Units
TABLE 53 US Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
TABLE 54 US Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
TABLE 55 US Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
TABLE 56 US Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
TABLE 57 US Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
TABLE 58 US Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
TABLE 59 US Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
TABLE 60 US Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
TABLE 61 US Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
TABLE 62 US Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
TABLE 63 US Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
TABLE 64 US Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
TABLE 65 Canada Drug Eluting Stent Market, 2019 - 2022, USD Million
TABLE 66 Canada Drug Eluting Stent Market, 2023 - 2030, USD Million
TABLE 67 Canada Drug Eluting Stent Market, 2019 - 2022, Thousand Units
TABLE 68 Canada Drug Eluting Stent Market, 2023 - 2030, Thousand Units
TABLE 69 Canada Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
TABLE 70 Canada Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
TABLE 71 Canada Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
TABLE 72 Canada Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
TABLE 73 Canada Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
TABLE 74 Canada Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
TABLE 75 Canada Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
TABLE 76 Canada Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
TABLE 77 Canada Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
TABLE 78 Canada Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
TABLE 79 Canada Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
TABLE 80 Canada Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
TABLE 81 Mexico Drug Eluting Stent Market, 2019 - 2022, USD Million
TABLE 82 Mexico Drug Eluting Stent Market, 2023 - 2030, USD Million
TABLE 83 Mexico Drug Eluting Stent Market, 2019 - 2022, Thousand Units
TABLE 84 Mexico Drug Eluting Stent Market, 2023 - 2030, Thousand Units
TABLE 85 Mexico Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
TABLE 86 Mexico Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
TABLE 87 Mexico Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
TABLE 88 Mexico Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
TABLE 89 Mexico Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
TABLE 90 Mexico Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
TABLE 91 Mexico Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
TABLE 92 Mexico Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
TABLE 93 Mexico Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
TABLE 94 Mexico Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
TABLE 95 Mexico Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
TABLE 96 Mexico Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
TABLE 97 Rest of North America Drug Eluting Stent Market, 2019 - 2022, USD Million
TABLE 98 Rest of North America Drug Eluting Stent Market, 2023 - 2030, USD Million
TABLE 99 Rest of North America Drug Eluting Stent Market, 2019 - 2022, Thousand Units
TABLE 100 Rest of North America Drug Eluting Stent Market, 2023 - 2030, Thousand Units
TABLE 101 Rest of North America Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
TABLE 102 Rest of North America Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
TABLE 103 Rest of North America Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
TABLE 104 Rest of North America Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
TABLE 105 Rest of North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
TABLE 106 Rest of North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
TABLE 107 Rest of North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
TABLE 108 Rest of North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
TABLE 109 Rest of North America Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
TABLE 110 Rest of North America Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
TABLE 111 Rest of North America Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
TABLE 112 Rest of North America Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
TABLE 113 Key Information – Abbott Laboratories
TABLE 114 Key Information – Boston Scientific Corporation
TABLE 115 Key Information – Terumo Corporation
TABLE 116 Key Information – Medtronic PLC
TABLE 117 Key Information – Biosensors International Group, Ltd.
TABLE 118 Key Information – Cook Medical, Inc.
TABLE 119 Key Information – B. Braun Melsungen AG
TABLE 120 Key Information – Biotronik SE & Co. KG
TABLE 121 Key Information – Lepu Medical Technology Co., Ltd
TABLE 122 Key Information – Alvimedica
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Drug Eluting Stent Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Drug Eluting Stent Market
FIG 4 Porter’s Five Force Analysis: Drug Eluting Stent Market
FIG 5 North America Drug Eluting Stent Market share by Application, 2022
FIG 6 North America Drug Eluting Stent Market share by Application, 2030
FIG 7 North America Drug Eluting Stent Market by Application, 2019 - 2030, USD Million
FIG 8 North America Drug Eluting Stent Market share by Coating Type, 2022
FIG 9 North America Drug Eluting Stent Market share by Coating Type, 2030
FIG 10 North America Drug Eluting Stent Market by Coating Type, 2019 - 2030, USD Million
FIG 11 North America Drug Eluting Stent Market share by Country, 2022
FIG 12 North America Drug Eluting Stent Market share by Country, 2030
FIG 13 North America Drug Eluting Stent Market by Country, 2019 - 2030, USD Million
FIG 14 SWOT Analysis: Abbott Laboratories
FIG 15 SWOT Analysis: Boston Scientific Corporation
FIG 16 SWOT Analysis: Terumo Corporation
FIG 17 Recent strategies and developments: Medtronic PLC
FIG 18 SWOT Analysis: Medtronic PLC
FIG 19 SWOT Analysis: Biosensors International Group, Ltd.
FIG 20 SWOT Analysis: Cook Medical, Inc
FIG 21 SWOT Analysis: B. Braun Melsungen AG
FIG 22 SWOT Analysis: Biotronik SE & Co. KG
FIG 23 SWOT Analysis: Lepu Medical Technology Co., Ltd
FIG 24 SWOT Analysis: Alvimedica